A Platform Study Exploring the Safety, Tolerability, Effects on the Tumor Microenvironment, and Efficacy of Pembrolizumab (MK-3475) + INCB Combinations in Advanced Solid Tumors

Type of Cancer
Solid Tumor

Phase

Division (Location)

Study ID

NCT#

Brief Description
A Platform Study Exploring the Safety, Tolerability, Effects on the Tumor Microenvironment, and Efficacy of Pembrolizumab (MK-3475) + INCB Combinations in Advanced Solid Tumors

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.